Literature DB >> 34184653

The Effect of Global DNA Methylation on PDCD5 Expression in the PBMC of Occupational Chromate Exposed Workers.

Feizai Ha1, Na Li, Changmao Long, Pai Zheng, Guiping Hu, Guang Jia, Tiancheng Wang.   

Abstract

OBJECTIVES: To evaluate the alteration of protein of programmed cell death 5 (PDCD5) in peripheral blood mononuclear cells (PBMC) and DNA methylation caused by hexavalent chromium exposure.
METHODS: There were 112 workers and 56 controls in this study. The chromium in RBC and urine, PBMC with PDCD5+, DNA methylation, urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and score of DNA damage were measured.
RESULTS: In chromate exposed workers, the percent of PBMC with PDCD5+, urine 8-OHdG, and score of DNA damage were significantly higher, whereas global DNA methylation was significantly lower. The binary logistic regression and generalized linear mixed model analysis showed that the percent of PBMC with PDCD5+ was significantly associated with global DNA hypomethylation.
CONCLUSIONS: The aberrant DNA hypomethylation plays an important role in PBMC apoptosis of occupational hexavalent chromium exposure.
Copyright © 2021 American College of Occupational and Environmental Medicine.

Entities:  

Year:  2021        PMID: 34184653     DOI: 10.1097/JOM.0000000000002192

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  Effects of Sodium Chromate Exposure on Gene Expression Profiles of Primary Rat Hepatocytes (In Vitro).

Authors:  Xiaofeng Li; Abdel-Moneim Eid Abdel-Moneim; Jinling Hua; Lei Zhao; Zhongze Hu; Xunsheng Pang; Shujuan Wang; Zhihao Chen; Bing Yang
Journal:  Biol Trace Elem Res       Date:  2022-06-02       Impact factor: 3.738

2.  New Approach about the Signaling Crosstalk between IQGAPs/ NF- κB/IL-8 and PDCD5/p53/TRAIL Pathways that Modulate Malignant Transformation in Hepatocellular Carcinoma.

Authors:  Khairy M A Zoheir; Mohamed A Abdelhafez; Ahmed M Darwish; Karima F Mahrous
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.